Cargando…
Neuroleptic Malignant Syndrome After Re-introduction of Atypical Antipsychotics in a COVID-19 Patient
We present a case of neuroleptic malignant syndrome (NMS) in a 46-year-old white female from a state psychiatric hospital who also tested positive for coronavirus-2019 (COVID-19) (severe acute respiratory syndrome coronavirus, SARS-CoV-2) infection after re-introduction of her home antipsychotics me...
Autores principales: | Espiridion, Eduardo D, Mani, Valli, Oladunjoye, Adeolu O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980951/ https://www.ncbi.nlm.nih.gov/pubmed/33763319 http://dx.doi.org/10.7759/cureus.13428 |
Ejemplares similares
-
Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal
por: Maeda, Keisuke, et al.
Publicado: (2023) -
Illness Anxiety Disorder: A Case Report and Brief Review of the Literature
por: Espiridion, Eduardo D, et al.
Publicado: (2021) -
A Rare Case of Ganser Syndrome: Psychogenic or Organic?
por: Espiridion, Eduardo D, et al.
Publicado: (2020) -
Trends of Opioid Use Disorder and Associated Factors in Hospitalized Patients With Arthritis
por: Oladunjoye, Adeolu O, et al.
Publicado: (2020) -
Predictors and Outcomes of Invasive Mechanical Ventilation in Opioid Overdose Hospitalization in the United States
por: Oladunjoye, Adeolu O, et al.
Publicado: (2020)